Two distinct syndromes associated with dengue virus infection are prevalent in tropical Asia; dengue fever, a benign disease characterized by fever, myalgia, leucopenia and a maculo-papular rash and dengue hemorrhagic fever (DHF), accompanied by fever, shock, hemorrhagic diathesis and a significant mortality. 1 The dengue viruses, a group of antigenically related members of the Group B arthropod-borne virus family, are transmitted from man to man by the mosquito, Aedes aegypti. Multiple members of the group are known to be simultaneously transmitted in large urban areas of tropical Asia. Dengue disease syndromes of both types may occur concurrently, DHF usually is restricted to the indigenous population, while dengue fever may occur in both indigenous and non-indigenous residents of an area."
When dengue hemorrhagic fever was first described in the Philippines, two new dengue viruses, types 3 and 4 were recovered from patients.' Shortly thereafter, dengue strains recovered from DHF patients in Thailand were tentatively designated types 5 and 6.5 As one explanation of the malignant type of dengue fever, it was suggested that dengue viruses had acquired virulence properties.6 A corollary to this hypothesis was that virulence and surface antigen were genetically linked and thus, the "newer" types of dengue viruses were the cause of the severe dengue syndrome.
The hypothesis that DHF is due to a self-destructive host response has been proposed by Halstead and associates.7 They suggested that some persons are sensitized by their first dengue infection. In such a host the course of a second infection with a virus of a different type may be altered adversely by an immune response. The following kinds of evidence support this hypothesis: a) almost all patients with severe hemorrhagic fever (dengue shock syndrome) exhibit a secondary (IgG) dengue antibody response; b) the dengue shock syndrome occurs only in areas of tropical Asia where two or more types of dengue viruses are simultaneously or sequentially endemic; c) no single strain of dengue virus has been associated with dengue shock syndrome, at least four types having been isolated from patients; d) at most, one dengue virus has been isolated from a single patient, suggesting that symptoms are precipitated by a single infection, and e) the shock syndrome is not seen in short term residents of dengue endemic areas who, if infected, have primary but only rarely, secondary dengue infections.
This series of communications"8 extends our preliminary reports on dengue infections in man and summarizes extensive observations both on dengue viruses and the dengue infected host which appear to be related to pathogenetic mechanisms operating in this system.
The following paper presents an antigenic analysis of dengue virus strains and attempts to correlate these with the disease response in the host. 8 lated subcutaneously with 0.5 ml. of a 1:10 dilution of virus in 0.75% bovine albumin in phosphate buffered saline (BAPS). Virus was prepared by homogenizing a suspension of infected LLC-MK2 (continuous rhesus kidney) cell monolayers harvested on the sixth day after virus inoculation. Monkeys were bled six weeks or more after infection.
Tissue culture neutralization test. The property of BS-C-1 cells infected with dengue viruses to resist challenge with a cytopathic virus has been described.' Tube cultures of these cells were used to test for dengue neutralization antibodies using the virus dilution, serum-constant method. Virus-serum mixtures were incubated at 370C. for one hour. Equal amounts of normal mouse serum and virus dilutions were incubated similarly for estimation of virus titer. Chikungunya virus was used as a cytopathic challenge virus to test for dengue virus-induced cellular resistance. Results are expressed as log neutralization index (LNI). LNI of 1.7 or greater was considered significant neutralization.
Plaque reduction neutralization test. A preliminary communication has described the LLC-MK2 dengue virus plaque assay.' A strain of LLC-MK2 propagated at Yale University School of Medicine for an unknown period was used in these studies. Test conditions and techniques for propagation of cells differed somewhat from those reported earlier. Cells were grown in a medium consisting of Eagle's Basal Medium, 5% agamma calf serum, 5% calf serum, final concentrations of glutamine of 200 mM per ml., bicarbonate of 0.45 mg/ml. and penicillin and streptomycin, of 100 units and 100 mg/ml., respectively. Seven days after inoculation of 2 oz. plaque bottles with 7 ml. containing 120,000 cells/ml., monolayers were ready to use. Virus was diluted either in 0.75% BAPS, 20% agamma calf serum in phosphate buffered saline, pH 7.8-8.0 (PBS), or acetone extracted normal mouse ascitic fluid in PBS. After incubation under conditions described in the text, neutralization reaction in virus-serum mixture was stopped by one hundred-fold dilution in chilled diluent. Growth medium was poured off cell sheet and 0.5 ml. of the diluted virus-serum mixture added without washing cells. Tubes were then incubated at 370C. for 90 minutes, next, virus inoculum was removed and in a darkened room, agar overlay added. Agar overlay contained a final concentration of 1:10,000 (millipore filtered) neutral red and 1%o Noble agar; concentrations of other ingredients were identical to those in growth medium except that one half concentration of bicarbonate was used. The pH of agar overlay was approximately 7.9. Plaque bottles were held at 35-36°C. for was observed between dengue 1 and TH-Sman and dengue 2 and TH-36 viruses and antisera. Less significant neutralization was noted between dengue 1 and 3 viruses. During three years of preparation of hyperimmune mouse serum many lots of dengue 3 and 4 antisera failed to neutralize significantly homologous virus. It was found that use of frozen virus-brain seeds was not as suitable as fresh material in producing a good antibody response in mice. Table 2 illustrates the results of attempted identification of the 121 dengue viruses recovered in suckling mice. Of the total tested, 71 viruses were neutralized significantly by one or more antisera. Of 50 viruses neutralized either by dengue 2 or TH-36 antiserum, 23 were significantly serum titers to each of six prototype antigens varied from each other by two-to fourfold. Highest titers to prototype antigens often were within twofold of titers to homologous virus. Results by CF were sometimes quite specific. Usually there was a marked similarity in serum titers with dengue 1 and TH-Sman or dengue 2 and TH-36 antigens, respectively. In some instances, CF titers to two or more antigens (dl-4) differed by at most only twofold, making test results difficult to interpret. For this reason, a modification in the antiserum preparation method was introduced. Table 5 shows representative CF results obtained with mouse antiserum prepared by technique 2. In this system little heterologous reaction was observed. There was a consistently close correlation between serum titers to dengue 1 or TH-Sman and dengue 2 or TH-36 antigens, respectively. Results are illustrated in Tables 6 and 7 . weanling mice. A process of blind intracerebral passage of viruses in suckling mice, similar to that used to recover dengue viruses from human serum, had to be employed to adapt tissue culture passage strains to mice. For a large number of tissue culture viruses this was done and antiserum prepared in mice and virus identified as described above.
Plaque reduction test. The inadequacies apparent in each of the identification systems described led to a search for a more discriminating and yet versatile technique. A plaque reduction test using the LLC-MK2 plaque assay system fulfilled these criteria. Studies of the neutralization characteristics of Macaca irus immune serum by some of us had led to a highly reproducible dengue virus identification technique applicable to virus from any host.'8 In the Yale laboratory these results have been extended to antisera prepared in Macaca mulatta. There appears to be an important advantage in using the latter species. More than 80 young adults of this species, Cross neutralization tests between dengue types 1-4 and TH-36 and THSman strains using monkey antisera are illustrated in Table 9 . Also included are neutralization data for dengue strain 13711 isolated from a hemorrhagic fever patient in the 1964 Ubol, Thailand outbreak.' These data show nearly identical 50 percent serum plaque reduction titers between dengue 1, TH-Sman and 13711 viruses and antisera and between dengue 2 and TH-36 viruses and antisera, respectively. Table 10 shows further application of Macaca mzulatta antisera to the typing of tissue culture adapted dengue strains. It was of interest that 1950-63 dengue strain was poorly neutralized by homologous as well as two different heterologous dengue 2 immune sera. In contrast, the antibody produced in two monkeys following infection with 1950-63 strain was nearly equal in titer to that produced by animals infected with 16681 dengue 2 strain.
Of (4.) A virus-dilution serum-constant neutralization test using dengue mouse immune serum indicated antigenic dissimilarity between the Hawaii and TH-Sman dengue 1 strains and between New Guinea C and TH-36 dengue 2 strains but two other test systems (complement fixation test of mouse dengue immune sera to Thailand isolates and plaque reduction neutralization test using serum obtained from infected monkeys) suggested that these two pairs of viruses are closely identical. These observations are similar to conclusions obtained in an immuno-electrophoretic study of dengue viruses,'9 and an analysis of dengue viruses by plaque reduction using monkey immune serum. '8 No viruses were recovered from patients or mosquitoes in Thailand from 1962-4 that consistently resembled TH-36 or TH-Sman in more than one identification system. Evidence obtained in the virus dilution neutralization test in BS-C-1 cells supporting the antigenic distinctness of these viruses from dengue 2 and 1, respectively, must be qualified. Results obtained in this system were not always reproducible; further, many lots of immune sera neutralized dengue viruses only poorly, or at threshold LNI values. We believe the variations observed may result from poorly understood factors that influence the completeness or reversibility of antibody-virus complexing. These factors could be extraneous to the antigenic composition of studied virus strains.
In a separate study we present results from an antigenic analysis of a large number of dengue strains.8 These studies suggest that the antigenic composition of dengue virus strains of the same type do differ. It is quite apparent that in some systems dengue viruses are poorly neutralized by antibody. Under these circumstances, immune sera containing antibodies to the greatest percentage of the antigenic mosaic of a test strain may neutralize that virus better than another virus with a less complete spectrum of antigenic sites. Does this imply that these strains are different enough to produce sequential infection in the same individual (i.e., are they different types) ? We believe not. Based upon antibody responses to infection, the monkey and the human2 distinguish in dengue viruses a major antigenic determinant of which there are, apparently, only four. At this stage in the technology of arboviruses, the most biologically relevant answer to the question of how many distinct dengue types there are might be derived from cross protection studies in susceptible hosts and not from in vitro antigenic analyses; dengue cross protection studies in primates are in progress in our laboratory.
SUMMARY
Two syndromes, a severe and sometimes fatal hemorrhagic fever (DHF), and benign dengue fever (DF), are associated with dengue infection in the human being. This series of papers describes studies of the properties of dengue viruses and aspects of the disease response in the host in an attempt to explain why these divergent syndromes occur. It has been postulated that virulent dengue disease is associated with infection by dengue types 3 and 4 and proposed types 5 and 6, while classic dengue fever is caused by types 1 and 2. This paper, the largest experience reported to date, summarizes comparative results obtained in typing 295 dengue viruses recovered from arthropods, DHF and DF cases in Thailand during a 3-year period, 1962-64. When dengue isolates were neutralized by antisera prepared in mice to prototype dengue types 1-4, TH 36 (type 5?) and TH-Sman (type 6?), and assayed in a continuous grivet monkey kidney cell tube test, some more nearly resembled the latter two Thai strains than dengue types 1-4. When antibodies to dengue isolates were produced in mice by a small number of antigenic stimuli, when tested by complement fixation, these reacted with only one of the four prototype dengue antigens; TH-Sman and TH-36 antigens produced the same titers as dengue types 1 and 2, respectively. Similar results were obtained when isolates were neutralized by prototype dengue immune sera made in monkeys and assayed in a plaque reduction neutralization test. The latter two identification methods were more reproducible than the former. These data support classification of the studied dengue viruses into four, not six, types and are not compatible with the hypothesis that associates DHF with "newer" dengue virus types. Commercially purchased North Indian Macaca mulatta were found to be satisfactory for production of specific dengue typing antisera. A single agar overlay dengue plaque assay in LLC MK2 cells and a dengue plaque reduction neutralization test that utilizes microquantities of serum are described.
